Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Commits $9.5M for '$1000 Genome' Technology in FY 2010

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has issue three funding announcements that outline its plans for supporting the development of low-cost sequencing tools in the 2010 fiscal year.

The three grants under the "Revolutionary Genome Sequencing Technologies — The $1,000 Genome" program will award a total of $9.5 million in 2010 to develop tools that can help lower the cost of sequencing a full mammalian-sized genome. These studies could involve full-scale sequencing systems or components of the underlying genome sequencing systems, NHGRI said.

Through an R01 grant mechanism, NHGRI will fund between two and seven awards totaling up to $5 million in 2010 and again in 2011. Applicants for the program may seek funding for up to four years and for direct costs of up to $1.5 million per year.

An R21 program will award $2 million in 2010 and again in 2011 to between two and seven grants.

A third grant program, through the Small Business Innovation Research mechanism, will grant up to $2.5 million in 2010 to between two and five projects, while future funding amounts may vary.

Under the SBIR program, Phase I grants will receive up to $250,000 in total costs per year for up to two years and Phase II grants will receive up to $1.5 million for as many as three years, NHGRI said.

The Scan

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.